What's more, an ointment containing the peptide effectively treated wounds infected with methicillin - resistant Staphylococcus aureus (MRSA) and the increasingly common hospital infection bacterium Acinetobacter baumannii in mice and on laboratory samples of human skin. (aaas.org)
Reporting of extensively drug - resistant A. baumannii infection is not required by most public health jurisdictions in the United States, and clinical laboratories generally do not test for an organism's underlying genetic resistance mechanisms. (sciencedaily.com)
Like Staphylococcus, another common pathogen, A. baumannii poses the biggest threat to hospitalized patients whose immune systems are already weakened by injury or illness. (discovermagazine.com)